Ching-Ping Chen - Concepedia

Author

Ching-Ping Chen

National Health Research Institutes

Also Known As

Ching-Ping Chen

Publications

756

Citations

H-Index

Concepts

All Affiliations

National Health Research Institutes National Yang Ming Chiao Tung University National Tsing Hua University Pondicherry University Taipei Medical University

About

Ching-Ping Chen is an author at National Health Research Institutes specializing in medicine, medicinal chemistry, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	218
2	Natural Sciences	3	3	164
3	Molecular Biology	3	3	175
4	Cell Biology	2	2	163
5	Biochemistry	1	1	43

Ching-Ping Chen

Publications

731

Citations

H-Index

Page 1

	Year	Citations
BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity<b><i>in Vivo</i></b> Ching‐Chuan Kuo, Hsing‐Pang Hsieh, Wen-Yu Pan, Cancer Research	2004	198
Synthesis and Biological Evaluation of <i>N</i>-Heterocyclic Indolyl Glyoxylamides as Orally Active Anticancer Agents Wen-Tai Li, Der-Ren Hwang, Ching-Ping Chen, Journal of Medicinal Chemistry	2003	159
Design and Synthesis of Tetrahydropyridothieno[2,3-<i>d</i>]pyrimidine Scaffold Based Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors: The Role of Side Chain Chirality and Michael Acceptor Group for Maximal Potency Chia-Hsien Wu, Mohane Selvaraj Coumar, Chang-Ying Chu, Journal of Medicinal Chemistry Kinase InhibitorsMolecular BiologySide Chain ChiralityMaximal PotencyPharmaceutical Chemistry	2010	109
Synthesis and Evaluation of 3-Aroylindoles as Anticancer Agents: Metabolite Approach Yu-Shan Wu, Mohane Selvaraj Coumar, Jang‐Yang Chang, Journal of Medicinal Chemistry	2009	89
Aurora kinase inhibitors reveal mechanisms of HURP in nucleation of centrosomal and kinetochore microtubules Jiun-Ming Wu, Chiung-Tong Chen, Mohane Selvaraj Coumar, Proceedings of the National Academy of Sciences Molecular BiologyCytoskeletonCell CycleAurora Kinase InhibitorsTumor Biology	2013	54
Synthesis and Biological Activities of 2-Amino-1-arylidenamino Imidazoles as Orally Active Anticancer Agents Wen-Tai Li, Der-Ren Hwang, Jen-Shin Song, Journal of Medicinal Chemistry Vivo Anticancer ActivitiesMedicinal ChemistryBiochemistryMedicineNatural Sciences	2010	43
Discovery of a Furanopyrimidine-Based Epidermal Growth Factor Receptor Inhibitor (DBPR112) as a Clinical Candidate for the Treatment of Non-Small Cell Lung Cancer Shu‐Yu Lin, Yung Chang Hsu, Yi-Hui Peng, Journal of Medicinal Chemistry	2019	35
Discovery of BPR1K871, a quinazoline based, multi-kinase inhibitor for the treatment of AML and solid tumors: Rational design, synthesis, <i>in vitro</i> and <i>in vivo</i> evaluation Yung Chang Hsu, Mohane Selvaraj Coumar, Wen-Chieh Wang, Oncotarget	2016	20
Antiangiogenic activities and cisplatin-combined antitumor activities of BPR0L075. Ching-Ping Chen, Chih-Bo Hu, Kai‐Chia Yeh, PubMed	2010	12
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutations Chiung-Tong Chen, John T.-A. Hsu, Wen‐Hsing Lin, European Journal of Medicinal Chemistry Medicinal ChemistryDrug TargetMedicineNatural SciencesRational Drug Design	2015	12

Page 1